Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 213.40M | $ 157.40M | $ 131.10M | $ 134.10M | $ 125.50M |
Total Assets | $ 2.74B | $ 2.20B | $ 2.01B | $ 1.88B | $ 1.88B |
Total Debt | $ 713.00M | $ 432.20M | $ 411.30M | $ 390.30M | $ 440.50M |
Net Debt | $ 499.60M | $ 274.80M | $ 280.20M | $ 256.20M | $ 315.00M |
Total Liabilities | $ 1.11B | $ 793.90M | $ 736.10M | $ 710.30M | $ 759.20M |
Stockholders Equity | $ 1.63B | $ 1.40B | $ 1.28B | $ 1.17B | $ 1.12B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |